A long list of cancer treatment drugs are in short supply, prompting doctors to make difficult decisions about how they treat their patients.
According to the FDA, 14 drugs used for chemotherapy are under a shortage. One of those drugs is carboplatin, which is often used to treat breast cancer as well as other cancers, including ovarian cancer, uterine cancer and lung cancer.
"To tell a patient that we have this great treatment and it's going to work, but we can't give it to you because it's in short supply is really, I think, one of the hardest things," Dr. Teplinsky said. "How is that going to impact the data if we can't give patients the drug that they need? So there, you know, the repercussions are really immense," Dr. Teplinsky said.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Shortage of lifesaving chemo drugs adds to cancer patients' fearsThe FDA says more than a dozen cancer drugs are in short supply, including Carboplatin.
Read more »
Medicare plans to pay for Alzheimer's drugs that win full FDA approvalMedicare says it will pay for new Alzheimer’s drugs that are granted full approval from the FDA, although it will require physicians to collect data on how well the drugs perform in the real world.
Read more »
FDA warns about safety risks of tailored weight-loss drugsThe U.S. Food and Drug Administration (FDA) warned about the safety risks of using compounded or custom-made versions of popular weight-loss drugs such as Wegovy and diabetes drug Ozempic.
Read more »
FDA-approved Alzheimer’s drugs will be covered by Medicare, with some limitations, CMS says | CNNThe Centers for Medicare & Medicaid Services announced Thursday a plan to cover a new class of Alzheimer’s disease drugs if they receive full approval from the US Food and Drug Administration – and with some limitations.
Read more »
FDA warns about safety of 'off-brand' versions of Ozempic, WegovyFederal regulators are warning about safety concerns amid the rising popularity of drugs like Ozempic and Wegovy for weight loss. The FDA is warning consumers that off-brand forms of the medications could be unsafe.
Read more »
Pfizer gets FDA approval for RSV vaccine Abrysvo in older adultsPfizer Inc. said late Wednesday that the Food and Drug Administration approved its respiratory syncytial virus vaccine Abrysvo for older adults. The drug...
Read more »